| GC39602-100mg |
|
147816-24-8 |
Cefcapene pivoxil hydrochloride hydrate
|
0 |
C23H32ClN5O9S2 |
|
|
|
| GC39602-50mg |
|
147816-24-8 |
Cefcapene pivoxil hydrochloride hydrate
|
0 |
C23H32ClN5O9S2 |
|
|
|
| GC39602-25mg |
|
147816-24-8 |
Cefcapene pivoxil hydrochloride hydrate
|
0 |
C23H32ClN5O9S2 |
|
|
|
| GC39601-50mg |
|
74298-63-8 |
Chlormidazole hydrochloride
|
0 |
C15H14Cl2N2 |
|
|
|
| GC39601-25mg |
|
74298-63-8 |
Chlormidazole hydrochloride
|
0 |
C15H14Cl2N2 |
|
|
|
| GC39600-100mg |
|
8047-67-4 |
|
0 |
— |
|
|
|
| GC39599-500mg |
|
23783-42-8 |
Tetraethylene glycol monomethyl ether
|
0 |
C9H20O5 |
|
|
|
| GC39599-250mg |
|
23783-42-8 |
Tetraethylene glycol monomethyl ether
|
0 |
C9H20O5 |
|
|
|
| GC39598-500mg |
|
117-78-2 |
Anthraquinone-2-carboxylic acid
|
0 |
C15H8O4 |
|
|
|
| GC39598-250mg |
|
117-78-2 |
Anthraquinone-2-carboxylic acid
|
0 |
C15H8O4 |
|
|
|
| GC39597-500mg |
|
5617-32-3 |
|
0 |
C14H30O8 |
|
|
|
| GC39597-250mg |
|
5617-32-3 |
|
0 |
C14H30O8 |
|
|
|
| GC39596-500mg |
|
870487-08-4 |
|
0 |
C16H30N4O6 |
|
|
|
| GC39596-250mg |
|
870487-08-4 |
|
0 |
C16H30N4O6 |
|
|
|
| GC39595-50mg |
|
2238821-31-1 |
|
0 |
C36H46N6O3 |
|
|
|
| GC39595-10mg |
|
2238821-31-1 |
|
0 |
C36H46N6O3 |
|
|
|
| GC39595-5mg |
|
2238821-31-1 |
|
0 |
C36H46N6O3 |
|
|
|
| GC39595-1mg |
|
2238821-31-1 |
|
0 |
C36H46N6O3 |
|
|
|
| GC39594-10mg |
|
— |
Nucleoprotein (396-404) (TFA)
|
0 |
C52H72N13F3O16 |
|
|
|
| GC39594-5mg |
|
— |
Nucleoprotein (396-404) (TFA)
|
0 |
C52H72N13F3O16 |
|
|
|
